December arabica coffee (KCZ25 ) on Wednesday closed down -19.05 (-4.51%), and January ICE robusta coffee (RMF26 ) closed ...
BioCryst Pharmaceuticals' stock narrative shifted recently as analysts adjusted their fair value estimate from $20.27 to $19.73 per share. This modest decrease follows the company’s acquisition of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback